InflaRx NV (IFRX)

0.92 +0.04 (+4.32%) USD  |  NASDAQ  |  Feb 25, 11:10
More

InflaRx Security Sold Not Yet Repurchased (Quarterly)

Security Sold Not Yet Repurchased (Quarterly) Chart

View Security Sold Not Yet Repurchased (Quarterly) for IFRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Security Sold Not Yet Repurchased (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Security Sold Not Yet Repurchased (Quarterly) Range, Past 5 Years

View Security Sold Not Yet Repurchased (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Security Sold Not Yet Repurchased (Quarterly) Benchmarks

View Security Sold Not Yet Repurchased (Quarterly) Benchmarks
Start Trial
CDT Equity, Inc. --
LENZ Therapeutics, Inc. --
Liminatus Pharma, Inc. --
Oruka Therapeutics, Inc. --
Maze Therapeutics, Inc. --